Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.

Li Z, Yang N, Lei X, Lin C, Li N, Jiang X, Wei X, Xu B.

J Clin Lab Anal. 2019 Jun 14:e22950. doi: 10.1002/jcla.22950. [Epub ahead of print]

PMID:
31199015
2.

Variation at APOE and STH loci and Alzheimer's disease.

Zuo L, van Dyck CH, Luo X, Kranzler HR, Yang BZ, Gelernter J.

Behav Brain Funct. 2006 Apr 7;2:13.

3.

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

BMC Neurol. 2008 Apr 16;8:9. doi: 10.1186/1471-2377-8-9.

4.

Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.

Agarwal R, Tripathi CB.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):575-82. Review.

PMID:
25551132
5.

APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area.

Fan YY, Cai QL, Gao ZY, Lin X, Huang Q, Tang W, Liu JH.

Brain Res Bull. 2017 Jun;132:39-43. doi: 10.1016/j.brainresbull.2017.04.017. Epub 2017 Apr 29.

PMID:
28461186
6.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

7.

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM.

JAMA. 1997 Oct 22-29;278(16):1349-56.

PMID:
9343467
8.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
9.

Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.

Jiang Y, He T, Deng W, Sun P.

Clin Interv Aging. 2017 Nov 13;12:1941-1949. doi: 10.2147/CIA.S143632. eCollection 2017.

10.

Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Al-Asmary SM, Kadasah S, Arfin M, Tariq M, Al-Asmari A.

Arch Med Sci. 2015 Aug 12;11(4):869-76. doi: 10.5114/aoms.2015.53308. Epub 2015 Aug 11.

11.

Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.

Kim HC, Kim DK, Choi IJ, Kang KH, Yi SD, Park J, Park YN.

Psychiatry Clin Neurosci. 2001 Apr;55(2):115-20.

12.

Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Su WH, Shi ZH, Liu SL, Wang XD, Liu S, Ji Y.

Oncotarget. 2017 Jul 4;8(27):43721-43732. doi: 10.18632/oncotarget.17341.

13.

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang JJ, Hsu WC, Chen YL, Toga AW.

JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.

14.

Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms.

Gozalpour E, Kamali K, Mohammd K, Khorshid HK, Ohadi M, Karimloo M, Mirabzadeh A, Fotouhi A.

Iran J Public Health. 2010;39(2):1-6. Epub 2010 Jun 30.

15.

The effects of APOE on the functional architecture of the resting brain.

Trachtenberg AJ, Filippini N, Ebmeier KP, Smith SM, Karpe F, Mackay CE.

Neuroimage. 2012 Jan 2;59(1):565-72. doi: 10.1016/j.neuroimage.2011.07.059. Epub 2011 Aug 7.

PMID:
21851856
16.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
17.

The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.

Luo JQ, Ren H, Banh HL, Liu MZ, Xu P, Fang PF, Xiang DX.

Front Physiol. 2017 Dec 12;8:1031. doi: 10.3389/fphys.2017.01031. eCollection 2017.

18.

[ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].

Hernández-Charro B, Moreno S, Valiente A, Manubens JM, Villar MD, Ramos-Arroyo MA.

Med Clin (Barc). 2004 Sep 4;123(7):251-4. Spanish.

PMID:
15482730
19.

Increased CSF cortisol in AD is a function of APOE genotype.

Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA.

Neurology. 2001 Apr 24;56(8):1094-8.

PMID:
11320185
20.

Apolipoprotein E gene in physiological and pathological aging.

Ferri E, Gussago C, Casati M, Mari D, Rossi PD, Ciccone S, Cesari M, Arosio B.

Mech Ageing Dev. 2019 Mar;178:41-45. doi: 10.1016/j.mad.2019.01.005. Epub 2019 Jan 15.

PMID:
30658061

Supplemental Content

Support Center